Maksim LabkouskiAlvotech (NASDAQ:ALVO) Thursday announced the acquisition of Xbrane Biopharma AB’s R&D operations and a biosimilar candidate, establishing a footprint…
JHVEPhotoThe FDA has accepted Alvotech (NASDAQ:ALVO) and Teva’s (NYSE:TEVA) Biologics License Applications for AVT05, their proposed biosimilar to the anti-inflammatory…
